Advances in the Management of Ovarian Cancer
Saturday, May 15, 2010
8:00 am – 12:00 pm
Joseph B. Martin Conference Center at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115
Quicklinks
Course Objectives | Agenda | Faculty
Registration Information
| Directions
Course Objectives
This course will provide medical, surgical, and radiation oncologists; gynecologists; primary care physicians; nurse practitioners; and other interested clinicians with an improved understanding of the current role of surgery and chemotherapy in the management of primary and recurrent ovarian cancer. Participants will also learn about novel treatments in development and explore approaches for managing challenging clinical problems related to ovarian cancer.
About the Gynecologic Oncology Program at Dana-Farber/Brigham and Women's Cancer Center
We offer comprehensive care for patients with proven or suspected gynecologic malignancies, including ovarian, endometrial, cervical, vulvar, vaginal, and trophoblastic cancers. Our multidisciplinary team of medical, surgical, and radiation oncologists, and pathologists, all have specific expertise in gynecologic cancers, and are dedicated to delivering the latest and most effective therapies to patients.
In addition, we are actively engaged in research that will improve our ability to diagnose gynecological malignancies, understand the biology of these cancers, and develop more effective therapies.
Agenda
8:00 am
Registration & Continental Breakfast
8:45 am
Welcome
Ross S. Berkowitz, MD
9:00 am
Recent Advances in the Surgical Management of Ovarian Cancer
Neil S. Horowitz, MD
9:30 am
Questions & Discussion
9:40 am
Latest Developments in the Initial Chemotherapy Treatment of Ovarian Cancer
Ursula A. Matulonis, MD
10:10 am
Questions & Discussion
10:20 am
Break
10:40 am
New Developments in the Chemotherapy Treatment of Recurrent Ovarian Cancer and Evolving New Treatments
Alexi Wright, MD
11:10 am
Questions & Discussion
11:20 am
Case Discussion of Challenging Clinical Problems in Ovarian Cancer
Panel:
Neil S. Horowitz, MD;
Ursula A. Matulonis, MD;
Alexi Wright, MD
12:00 pm
Closing Remarks
Ross S. Berkowitz, MD
Faculty
Ross S. Berkowitz, MD
Course Director
Director, Gynecologic Oncology
Dana Farber/Brigham and Women's Cancer Center;
William H. Baker Professor of Gynecology
Harvard Medical School
Neil S. Horowitz, MD
Director, Clinical Research in Gynecologic Oncology
Dana Farber/Brigham and Women's Cancer Center;
Assistant Professor of Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Ursula A. Matulonis, MD
Medical Director, Gynecologic Oncology
Dana Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Alexi Wright, MD
Medical Oncologist
Dana Farber/Brigham and Women's Cancer Center;
Instructor in Medicine
Harvard Medical School
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
Harvard Medical School designates this educational activity for a maximum of 2.75 AMA PRA Category 1 credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
Registration Information
Registration Fee: $35 and includes course materials and continental breakfast. The registration fee is non-refundable.
To register by mail
Mail registration form and payment to:
Ovarian Cancer CME
Attn: Kamira Wooten
44 Binney Street, OS 381
Boston, MA 02115
Registration form must be postmarked no later than May 5, 2010.
Click here for directions to the Joseph B. Martin Conference Centerl
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call (800) 553-3787.
